Terms: = Breast cancer AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791 AND Prognosis
4 results:
1. The Expression of CTLA-4 in breast Tumors and Tumor-Infiltrating Leukocytes Affects Patients' Systemic Inflammatory Status and Varies According to Their Molecular Subtypes.
Kern R; da Silva JC; Negretti F; Ferreira MO; Coletto MIO; de Oliveira ST; Alves FM; Scandolara TB; Rech D; Panis C
Inflammation; 2023 Oct; 46(5):1639-1652. PubMed ID: 37237069
[TBL] [Abstract] [Full Text] [Related]
2. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract] [Full Text] [Related]
3. The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment.
Kim JY; Jung HH; Ahn S; Bae S; Lee SK; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Aug; 6():31804. PubMed ID: 27545642
[TBL] [Abstract] [Full Text] [Related]
4. NF-kappa B genes have a major role in inflammatory breast cancer.
Lerebours F; Vacher S; Andrieu C; Espie M; Marty M; Lidereau R; Bieche I
BMC Cancer; 2008 Feb; 8():41. PubMed ID: 18248671
[TBL] [Abstract] [Full Text] [Related]
